Literature DB >> 9177426

Chronic lymphocytic leukemia: a changing natural history?

C Rozman1, F Bosch, E Montserrat.   

Abstract

There are some data suggesting that the natural history of chronic lymphocytic leukemia (CLL) may be changing, but a systematic analysis of this topic is lacking. To address this issue, we examined two cohorts of CLL patients in whom the diagnosis was established in 1960-1979 (group I) and in 1980-1989 (group II), respectively. Striking differences were observed between both cohorts. The diagnosis in the second group was established at higher age (65.8 vs 61.3 years; P = 0.0001), both in males (63.8 vs 59.1 years; P = 0.004) and females (68.3 vs 64.2 years; P = 0.01); the proportion of patients in whom the diagnosis was established in low-risk clinical stage (Binet's A) was significantly higher in group II (65.7% vs 42.6%; P < 0.001), and the survival was more than double in group II (median of 11.1 vs 5.3 years; P < 0.0001). Moreover, the impact of the disease on life expectancy was much lower in the more recent cohort. These differences may be due, at least in part, to changes in the natural history of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9177426     DOI: 10.1038/sj.leu.2400679

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

1.  Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion.

Authors:  M C Lanasa; W A Hogge; C Kubik; J Blancato; E P Hoffman
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 2.  Current and developing chemotherapy for CLL.

Authors:  Emili Montserrat
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

3.  Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.

Authors:  Stefano Molica; Francesca R Mauro; Diana Giannarelli; Francesco Lauria; Agostino Cortelezzi; Maura Brugiatelli; Vincenzo Liso; Antonio Cuneo; Robin Foà
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

4.  The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.

Authors:  Stefano Molica; Francesca R Mauro; Vincenzo Callea; Diana Giannarelli; Francesco Lauria; Bruno Rotoli; Agostino Cortelezzi; Vincenzo Liso; Robin Foà
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

5.  Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Kari G Rabe; Neil E Kay; Clive S Zent; Diane F Jelinek; Megan S Reinalda; Susan M Schwager; Debbie A Bowen; Susan L Slager; Curtis A Hanson; Timothy G Call
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

Review 6.  Optimizing frontline therapy of CLL based on clinical and biological factors.

Authors:  Kirsten Fischer; Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells.

Authors:  Laurent Boissel; Monica Betancur; Winfried S Wels; Hande Tuncer; Hans Klingemann
Journal:  Leuk Res       Date:  2009-01-14       Impact factor: 3.156

8.  Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

Authors:  Shanique Palmer; Curtis A Hanson; Clive S Zent; Luis F Porrata; Betsy Laplant; Susan M Geyer; Svetomir N Markovic; Timothy G Call; Deborah A Bowen; Diane F Jelinek; Neil E Kay; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2008-04-01       Impact factor: 6.998

9.  Validation of a new prognostic index for patients with chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Greg Jenkins; Timothy G Call; Clive S Zent; Susan Slager; Deborah A Bowen; Susan Schwager; Curtis A Hanson; Diane F Jelinek; Neil E Kay
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

10.  B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.

Authors:  Tait D Shanafelt; Neil E Kay; Greg Jenkins; Timothy G Call; Clive S Zent; Diane F Jelinek; William G Morice; Justin Boysen; Liam Zakko; Susan Schwager; Susan L Slager; Curtis A Hanson
Journal:  Blood       Date:  2008-11-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.